Loading clinical trials...
Loading clinical trials...
The purpose of this study is to examine the effects of the study drug--Galantamine-on patients with subarachnoid hemorrhage (SAH). The study will examine how patients with SAH will tolerate the study ...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
The University of Texas Health Science Center, Houston
NCT07294118 · Subarachnoid Hemorrhage, Aneurysmal, Headache, and more
NCT07160088 · Aneurysmal Subarachnoid Hemorrhage (aSAH)
NCT07307508 · Aneurysmal Subarachnoid Hemorrhage (aSAH), Headache Disorders
NCT06119061 · Subarachnoid Hemorrhage, Aneurysmal
NCT06409364 · Aneurysmal Subarachnoid Hemorrhage
Houston Methodist Hospital Texas Medical Center
Houston, Texas
The University of Texas Health Science Center at Houston
Houston, Texas
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions